批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/07/18 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/03/04 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/08/25 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/11/27 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/06/07 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/12/20 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/10/24 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/12/19 |
SUPPL-14(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2014/03/27 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/02/25 |
SUPPL-13(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2012/11/28 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/10/09 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/09/28 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/01/20 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/06/30 |
SUPPL-7(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/06/21 |
SUPPL-5(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/09/03 |
SUPPL-6(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/03/04 |
SUPPL-4(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/10/09 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/01/15 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/02/27 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:ESOMEPRAZOLE MAGNESIUM 剂型/给药途径:FOR SUSPENSION, DELAYED RELEASE;ORAL 规格:EQ 10MG BASE/PACKET 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022101 |
001 |
NDA |
NEXIUM |
ESOMEPRAZOLE MAGNESIUM |
FOR SUSPENSION, DELAYED RELEASE;ORAL |
EQ 10MG BASE/PACKET |
Prescription |
Yes |
No |
AB |
2008/02/27
|
ASTRAZENECA |
211752 |
001 |
ANDA |
ESOMEPRAZOLE MAGNESIUM |
ESOMEPRAZOLE MAGNESIUM |
FOR SUSPENSION, DELAYED RELEASE;ORAL |
EQ 10MG BASE/PACKET |
Prescription |
No |
No |
AB |
2020/03/23
|
CIPLA |